We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You can change your cookie settings at any time.
Find information and services
Search for a department and find out what the government is doing
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Seeks views on proposed changes to the Human Medicines Regulations and the Medicines Act.
We're looking for your views on how medical devices will be regulated across the United Kingdom (UK) in the future.
This consultation, on the future regulation of medical devices, comes at a…
We are updating our current regulatory regime for medical devices in the…
Our Aims The Medicines and Healthcare products Regulatory Agency (MHRA) is…
The purpose of this consultation is to obtain your views on how the…
Chapter 1: Scope of the Regulations The Medical Devices Regulations 2002…
Under section 45(3) of the Medicines and Medical Devices Act 2021 the…
1. Introduction You can read the MHRA Privacy Notice to find out in…
The number and range of medical devices is vast and includes most…
Section 1 - Medical device and IVD scope Background 1.1 The Medical…
Section 5 - Classification of general medical devices Background 5.1 Under…
We’d value your views to help shape the introduction of a new regulatory framework for products supplied at the point of care.
1. Executive Summary New types of innovative products are increasingly…
We're looking for your views and comments on our proposed legislative changes to clarify the legal basis for EAMS.
A 3-week public consultation on a proposal to make Hana 75 microgram film-coated tablets (Desogestrel) available from pharmacies.
A 3-week consultation on a proposal to make Lovima 75 microgram film-coated tablets (Desogestrel) available from pharmacies.
We’re looking for views from patients and the public on how we engage with them.
The MHRA is asking for views on a proposal to make Nuromol Dual Action Pain Relief 200mg/500mg tablets (ibuprofen/paracetamol) available without prescription in general sales outlets, such a supermarkets.
We want your comments on the clarity and wording of our new guidance
Call for information to support a review of isotretinoin, a treatment for severe acne. This review is being undertaken by the Medicines and Healthcare products Regulatory Agency with advice from the Commission on Human Medic…
This consultation asks for views on the application of AQbD principles to pharmacopoeial standards for medicinal products.
Work is ongoing to address the comments and feedback from respondents to the consultation. Publication of our report on the consultation has been delayed in light of the Agency’s response during the ongoing coronavirus situa…
This consultation seeks your views on how the Medicines and Healthcare products Regulatory Agency’s (MHRA) legislation and regulatory processes would have to be modified in the event of the UK not securing a deal with the EU…
We are seeking views on a proposal to make Acnecide Face 5% w/w Gel and Acnecide Face Wash 5% w/w Gel available from general sales outlets.
We are developing a strategy for the creation of pharmacopoeial public quality standards for biological medicines. We would like your input regarding how they are used & can be improved as well as feedback on our draft s…
We are asking for views on a new draft version on our guidance for users, carers and staff on the safe use of bed rails.
We are considering making Colourstart Test 65mcg Cutaneous Patch available to buy without prescription from retail outlets. We always want to involve the public and healthcare professionals in decisions that affect them. W…
This consultation invites views on the proposed steps we intend to take to make sure the UK meets its obligations to transpose the 'safety features' provisions of the Falsified Medicines Directive (FMD).
We are reviewing the impact of the Human Medicines Regulations 2012 (‘the 2012 Regulations’). This is part of a wider exercise within government to test the impact of legislation five years after implementation.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.